Peihong Wu - Publications, H-index & Citations

吴

吴沛宏 (Peihong Wu)

sun yat-sen university

37H指数

171论文数

3.8K被引数

收录论文 64

发表时间

A study on the correlation between the mean platelet volume to monocyte count ratio and long-term prognosis in patients with newly diagnosed coronary artery disease 关于平均血小板体积与单核细胞计数比值与初诊冠心病患者长期预后的相关性研究

Frontiers in Cardiovascular Medicine

IF2.9

2025-10-09

OAAI

Wei Fu†; Honghou He†; Jianan Xu; Peihong Wu; Qian Zhang; Mei Wei; Linan Duan; Gang Wang; Le Wang; Zelong Cao; Mingqi Zheng

Prognostic significance of FT3 levels in hypertrophic cardiomyopathy patients with HFpEF 肥厚型心肌病合并HFpEF患者FT3水平的预后意义

Frontiers in Cardiovascular Medicine

IF2.9

2025-08-23

OAAI

Zhen-Yu Yang†; Zhi-Yuan Zhang†; Wei-Jie Zhang†; Da Liu; Fu-Shi Piao; Xiangyu Yan; Fang-Tao Shi; Min Yang; Jing Chen; Sheng-song Zhu; Hong-Hou He; Pei-Hong Wu; Cheng Qian; Min Lin; Jun-Qing Feng; Chun-jin Lai

Refining Intra-Arterial Therapy Selection for Large Hepatocellular Carcinoma: A Deep Learning Approach Based on Covariate Interaction Analysis 基于协变量交互分析的巨大肝细胞癌动脉内疗法选择优化：一种深度学习方法

Journal of Hepatocellular Carcinoma

IF3.4

2025-07-11

OAAI

Chao An; Lei Li; Yang Luo; Mengxuan Zuo; Wendao Liu; Chengzhi Li; Peihong Wu

Machine learning-based decision support model for selecting intra-arterial therapies for unresectable hepatocellular carcinoma: A national real-world evidence-based study ( vol 131 , pg 832 , 2024)

BRITISH JOURNAL OF CANCER

IF6.8

2025-02-03

OAAI

An, Chao; Wei, Ran; Liu, Wendao; Fu, Yan; Gong, Xiaolong; Li, Chengzhi; Yao, Wang; Zuo, Mengxuan; Li, Wang; Li, Yansheng; Wu, Fatian; Liu, Kejia; Yan, Dong; Wu, Peihong; Han, Jianjun

Surgical resection versus thermal ablation: comparison of sequential options after successful TACE downstaging therapy for unresectable hepatocellular carcinoma

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

IF4.2

2025-01-01

OAAI

An, Chao; Wu, Songsong; Zuo, Mengxuan; Li, Wang; Li, Kai; Wu, Peihong

Multimodal imaging-based prediction of recurrence for unresectable HCC after downstage and resection-cohort study

INTERNATIONAL JOURNAL OF SURGERY

IF10.1

2024-09-01

OAAI

Jiang, Hanyu; Zuo, Mengxuan; Li, Wang; Zhuo, Shuiqing; Wu, Peihong; An, Chao

Machine learning-based decision support model for selecting intra-arterial therapies for unresectable hepatocellular carcinoma: A national real-world evidence-based study

BRITISH JOURNAL OF CANCER

IF6.8

2024-07-06

PREAI

An, Chao; Wei, Ran; Liu, Wendao; Fu, Yan; Gong, Xiaolong; Li, Chengzhi; Yao, Wang; Zuo, Mengxuan; Li, Wang; Li, Yansheng; Wu, Fatian; Liu, Kejia; Yan, Dong; Wu, Peihong; Han, Jianjun

Pseudo-capsulated Hepatocellular Carcinoma: Hepatic Arterial Infusion Chemotherapy Versus Transcatheter Arterial Chemoembolization

ACADEMIC RADIOLOGY

IF3.9

2024-03-01

PREAI

An, Chao; Yao, Wang; Zuo, Mengxuan; Li, Wang; Chen, Qifeng; Wu, Peihong

Camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and hepatic artery infusion chemotherapy for hepatocellular carcinoma in Barcelona Clinic Liver Cancer stage C (TRIPLET): a phase II study Camrelizumab (一种PD-1抑制剂) 加阿帕替尼 (一种VEGFR-2抑制剂) 和肝动脉灌注化疗治疗巴塞罗那临床肝癌C期 (三联) 的肝细胞癌: II期研究

Signal Transduction and Targeted Therapy

IF52.7

2023-10-27

OAAI

Tian-Qi Zhang; Zhi-Jun Geng; Meng-Xuan Zuo; Ji-Bin Li; Jin-Hua Huang; Zi-Lin Huang; Pei-Hong Wu; Yang-Kui Gu

Development and validation of prognostic nomograms for large hepatocellular carcinoma after HAIC

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

IF4.2

2023-04-17

OAAI

Yao, Wang; Wei, Ran; Jia, Jia; Li, Wang; Zuo, Mengxuan; Zhuo, Shuqing; Shi, Ge; Wu, Peihong; An, Chao

Postprogression treatment of lenvatinib plus PD-1 inhibitor in advanced hepatocellular carcinoma refractory to HAIC

CANCER

IF5.1

2023-04-07

PREAI

An, Chao; Fu, Yan; Li, Wang; Zuo, Mengxuan; Wu, Peihong

Infiltrative Hepatocellular Carcinoma: Transcatheter Arterial Chemoembolization Versus Hepatic Arterial Infusion Chemotherapy

FRONTIERS IN ONCOLOGY

IF3.3

2021-12-16

OAAI

An, Chao; Zuo, Mengxuan; Li, Wang; Chen, Qifeng; Wu, Peihong

Systemic Delivery of MicroRNA101 Potently Inhibits Hepatocellular Carcinoma In Vivo by Repressing Multiple Targets (vol 11, e1004873, 2015)

PLOS GENETICS

IF3.7

2021-12-08

OAAI

Zheng, Fang; Liao, Yi-Ji; Cai, Mu-Yan; Liu, Tian-Hao; Chen, Shu-Peng; Wu, Pei-Hong; Wu, Long; Bian, Xiu-Wu; Guan, Xin-Yuan; Zeng, Yi-Xin; Yuan, Yun-Fei; Kung, Hsiang-Fu; Xie, Dan

Distinguishing benign and malignant lesions on contrast-enhanced breast cone-beam CT with deep learning neural architecture search

EUROPEAN JOURNAL OF RADIOLOGY

IF3.3

2021-09-01

PREAI

Ma, Jingchen; He, Ni; Yoon, Jin H.; Ha, Richard; Li, Jiao; Ma, Weimei; Meng, Tiebao; Lu, Lin; Schwartz, Lawrence H.; Wu, Yaopan; Ye, Zhaoxiang; Wu, Peihong; Zhao, Binsheng; Xie, Chuanmiao

Consensus of Minimally Invasive and Multidisciplinary Comprehensive Treatment for Hepatocellular Carcinoma-2020 Guangzhou Recommendations

FRONTIERS IN ONCOLOGY

IF3.3

2021-07-02

OAAI

Chen, Qi-Feng; Li, Wang; Yu, Simon Chun-Ho; Chou, Yi-Hong; Rhim, Hyunchul; Yang, Xiaoming; Shen, Lujun; Dong, Annan; Huang, Tao; Huang, Jinhua; Zhang, Fujun; Fan, Weijun; Zhao, Ming; Gu, Yangkui; Huang, Zhimei; Zuo, Mengxuan; Zhai, Bo; Xiao, Yueyong; Kuang, Ming; Li, Jiaping; Han, Jianjun; Song, Wei; Ma, Jie; Wu, Peihong; Oncology, Asia-Pacific Assoc Image-Guided Therapy

ASTN1 is associated with immune infiltrates in hepatocellular carcinoma, and inhibits the migratory and invasive capacity of liver cancer via the Wnt/β-catenin signaling pathway

ONCOLOGY REPORTS

IF3.9

2020-07-24

OAAI

Chen, Qi-Feng; Shi, Feng; Huang, Tao; Huang, Chaoyun; Shen, Lujun; Wu, Peihong; Li, Wang

PD-L1 Under Regulation of miR-429 Influences the Sensitivity of Gastric Cancer Cells to TRAIL by Binding of EGFR

FRONTIERS IN ONCOLOGY

IF3.3

2020-07-22

OAAI

Lv, Jinqi; Guo, Tianshu; Qu, Xiujuan; Che, Xiaofang; Li, Ce; Wang, Shuo; Gong, Jing; Wu, Peihong; Liu, Yang; Liu, Yunpeng; Xu, Ling